Team leader

---

• PhD, MPhil, University of Cambridge UK; B.Sc(Hons) Biochemistry Imperial College London
• Marie Curie Postdoctoral Fellowship - TransCureResearch Institute Bern
• 13+ years research in endothelin-1 - 1st in world to create soluble form of G-protein coupled receptor (GPCR) in terms of ligand binding ability (In this case, for endothelin-1).  - Patented
• Winner Biotech startup weekend organized by Judge Business School in association with AstraZeneca UK

Ira has over 13 years experience as a management consultant, working on market entry strategy, growth strategy, start-up commercialization and program management. She started her career with A.T Kearney after completing her MBA from the Indian Institute of Management Ahmedabad (IIMA) and B. Computing (Hons) from the National University of Singapore. She worked with A.T Kearney for 6+ years and then was consulting for Aspire Advisors and various other clients in Hong Kong and Singapore. She is now working with ET-traps to support the commercialization, business planning, strategy and operations.

Professor Johnson is a Fellow of Royal Society (FRS), Fellow of Academy of Medical Sciences (FMedSci), Fellow of Royal College of Obstetricians and Gynaocologists (FRCOG) and Fellow of the Royal Society of Biology (FRSB). He is an Emeritus Professor of Reproductive Sciences from the University of Cambridge, UK. He has co-authored over 300 papers on reproductive and development science, history, ethics, law and medical education over the course of his career. Have to mention, he helped receive the Nobel Prize in Medicine on behalf of Dr Robert Edwards for their work on IVF while he was in Dr Edwards lab!

Shaun Grady is Senior Vice President of Business Development Operations with AstraZeneca. He leads their transaction execution, due diligence and Alliance and Integration Management function including their late stage and on market licensing and partnering, M&A and divestments. He is also  the Chair Investment Committee, CMS Ventures

Vidhi has over 9 years research experience working with Dabur Research Foundation and ET-traps Limited. She has a Master’s in Biotechnology from Amity Institute of Biotechnology. Vidhi has done a course on Writing in the Sciences (with Honors) and she, along with her teammates, completed the start-up accelerator program established by Cambridge Judge Business School as part of the Biotech Start-up competition. While in Dabur’s drug discovery unit, Vidhi developed expertise in cell culture and maintenance, cytotoxicity profiling, determining properties of molecules and laying down SOPs for laboratory experiments, equipment and procedures and ensuring their compliance.